Delivery Order SPE2DR25D1004-SPE2DR26FSWY2
- Not listed
- The Defense Logistics Agency awarded a $1,387.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of dextroamphetamine-amphetamine 30 mg capsules (100-count units). This is a non-set-aside competitive award with an ultimate completion date of December 16, 2025, and performance is based in Conshohocken, Pennsylvania, the company's headquarters location. The delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,225.39 to AmerisourceBergen Drug Corp for 100 capsules of dextroamphetamine-amphetamine 30 mg, with performance in Conshohocken, Pennsylvania and completion by August 11, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Dextroamphetamine-Amphetamine 30 mg capsules (100-count units) with a ceiling value of $1,021.84. This firm fixed-price delivery order, with an ultimate completion date of December 9, 2025, will be performed at the contractor's location in Conshohocken, Pennsylvania. The award was made without a set-aside designation, indicating open competitive procurement. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,695.44 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 30 mg capsules (100-count) on September 12, 2025, with completion expected by September 15, 2025. This firm fixed-price delivery order carries no set-aside designation and was awarded competitively. The pharmaceutical will be supplied from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,751.28 to AmerisourceBergen Drug Corp for the supply of dextroamphetamine-amphetamine 30 mg capsules (100 count) on December 10, 2025, with completion scheduled for December 11, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,310.10 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 30 mg capsules (100 count) on December 8, 2025, with completion targeted for December 9, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle...
- The Defense Logistics Agency issued a delivery order valued at $1,392.76 to AmerisourceBergen Drug Corp for Dextroamphetamine-Amphetamine 15 mg capsules (100-count units) on December 10, 2025, with a completion date of December 11, 2025. This firm fixed-price delivery order, which carries no set-aside designation, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $2,337.12 to AmerisourceBergen Drug Corp for 100 capsules of dextroamphetamine-amphetamine 20 mg. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by December 16, 2025. The order is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded a Delivery Order valued at $1,498.56 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100 count) on November 5, 2025, with completion scheduled for November 6, 2025. This non-competitive, firm fixed-price delivery order was fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, representing a routine pharmaceutical procurement under the company's existing contract vehicle with DLA. This...
- The Defense Logistics Agency (DLA) awarded a $2,917.12 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of dextroamphetamine-amphetamine 30 mg capsules (100-count units). This firm fixed price delivery order, with an ultimate completion date of September 4, 2025, represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the...
- SPE2DR25D1004Indefinite Delivery Contract
- SPE2DR25D1004-SPE2DR26FSWY2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,237.50 to AmerisourceBergen Drug Corp for 100-count bottles of Dextroamphetamine-Amphetamine 30 mg capsules. This is a firm fixed price delivery order with an ultimate completion date of December 23, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime vendor contract serves as a comprehensive vehicle enabling the contractor to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The pharmaceutical product being delivered under this order supports the Defense Health Agency and other federal healthcare systems requiring controlled pharmaceutical substances for medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 12/21/25 |